Shionogi & Co Ltd 2019 Integrated Report
Company: Shionogi & Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2019
Type: Integrated Report
Pages: 114
The report presents Shionogi's FY2018 performance, including record net sales of ¥363.7 billion and continued growth driven by its pharmaceutical portfolio. It describes a formal materiality assessment and identifies priorities including innovation, infectious diseases, healthcare access, human resources, human rights, supply chain management, environmental protection and governance. The report also highlights progress on climate action, including a goal to reduce CO2 emissions by 33% from the fiscal 2005 benchmark by fiscal 2020. Its non-financial data reports 5,233 consolidated employees and a 16.7% female Board representation rate.
Services
From bulk PDFs to structured indicators and machine-readable documents.